Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMJVGIH)

Drug Name

AIGIV Drug Info

Synonyms

Anthrax immune globulin therapy (intravenous); Anthrax immune globulin therapy (intravenous), Emergent

Indication

Disease Entry	ICD 11	Status	REF
Diabetic neuropathy	8C0Z	Phase 1/2	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Approved Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting Bacillus anthracis Protective antigen (Anthrax PA)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
ETI-204	DMBIYNH	Anthrax	1B97	Approved	[3]
------------------------------------------------------------------------------------

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Bacillus anthracis Protective antigen (Anthrax PA)	TTRLPUB	PAG_BACAN	Modulator	[2]

------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT00845650) Safety and Pharmacokinetics Study of Anthrax Immune Globulin Intravenous (AIGIV). U.S. National Institutes of Health.
2	Evaluation of intravenous anthrax immune globulin for treatment of inhalation anthrax. Antimicrob Agents Chemother. 2013 Nov;57(11):5684-92.
3	Efficacy of ETI-204 monoclonal antibody as an adjunct therapy in a New Zealand white rabbit partial survival model for inhalational anthrax. Antimicrob Agents Chemother. 2015 Apr;59(4):2206-14.